Further exploration of downstream targets regulating the fibroblast phenotype conversion by KMT2A revealed that changes in H3K4me3 modification was enriched in pathways related to oncogene aberrant transcription, breast cancer‐associated genes and basal cell carcinoma‐associated genes, providing insights for future research. The gene discussed is KMT2A; the disease is breast carcinoma.